IMPORTANT MESSAGE
Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
팟캐스트: 영국(UK)의 새로운 임상시험 규정(Clinical Trial Regulation) 대응 전략
Olive McCormick
Director of Quality, Almac Clinical Services
이번 Fierce Life Sciences 팟캐스트 에피소드에서는 Almac Clinical Services의 Quality Director인 Olive McCormick이 영국의 새로운 임상시험 규정을 효과적으로 대응하는 방법에 대한 전문적인 인사이트를 공유합니다.
Olive는 최신 규제 프레임워크가 스폰서에게 의미하는 바를 설명하고, 임상시험 운영에 미치는 실질적인 영향과 함께, 빠르게 변화하는 규제 환경 속에서 스폰서가 어떻게 자신 있게 대응할 수 있는지에 대해 설명합니다.
보다 심층적인 내용을 확인하고 싶으신가요?